| Acute Myeloid Leukemia with Genetic Abnormalities studied in …STUDIED_INderived200 of 264show all (up to 200) |
|---|
| → studied in | NCT07504458Phase 3 · recruiting Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06917911Phase 2 · recruiting Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Core Binding Factor Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00801489Phase 2 · recruiting Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02938858completed French Registry of First-line Treatment of Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07566585Phase 1 · withdrawn Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 Mutation · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with NPM1 Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05886049Phase 1 · recruiting A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with KMT2A Rearrangement | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06001788Phase 1 · recruiting Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with NPM1 Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03147612Phase 2 · active not recruiting Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02071901Phase 2 · completed Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03253848NA · active not recruiting Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia · condition mapped CURATED_BROADER · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02727803Phase 2 · recruiting Personalized NK Cell Therapy in CBT · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with a Variant KMT2A Rearrangement | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093470Phase 3 · completed Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00658814Phase 2 · active not recruiting Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02094794Phase 2 · active not recruiting Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07597941Phase 2/Phase 3 · not yet recruiting Lisaftoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085124Phase 3 · completed Daunorubicin Hydrochloride, Cytarabine and Oblimersen Sodium in Treating Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02688140Phase 3 · completed Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01409161Phase 2 · recruiting Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia · condition mapped CURATED_BROADER · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06222580Phase 1 · recruiting SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01627041Phase 2 · active not recruiting Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02390635Phase 1 · recruiting PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped CURATED_BROADER · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07503730Phase 3 · recruiting Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL). · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05735184Phase 1 · recruiting A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with NPM1 Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02339740Phase 3 · active not recruiting Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07296445Phase 3 · not yet recruiting A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301) · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869114Phase 2 · completed Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05024552Phase 1 · recruiting Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01139970Phase 1 · completed Veliparib and Temozolomide in Treating Patients With Acute Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06882031Phase 1 · completed Evaluate the Pharmacokinetics of Oral Arsenic Trioxide Solution Under Fasting and Fed Conditions, to Compare Intravenous Arsenic Trioxide, in Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07203885NA · completed AI-Assisted Acute Myeloid Leukemia Evaluation With the Leukemia End-to-End Analysis Platform (LEAP) Versus Clinician-Only Assessment · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01760655Phase 2 · completed Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07187505NA · active not recruiting Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07162116Phase 1 · recruiting A Study to Evaluate the Effect of XY0206 on the QTc Interval in Chinese Healthy Participants · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03333486Phase 2 · terminated Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07028073Phase 1/Phase 2 · recruiting A New Treatment of Newly Diagnosed KIT Mutation CBF-Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04687176Phase 2 · recruiting Frontline Oral Arsenic Trioxide for APL · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06982274Phase 2 · recruiting Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01822015early Phase 1 · completed Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588991Phase 1 · completed Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03686345Phase 2 · terminated Midostaurin Associated With Standard Chemotherapy in Patients With Core-binding Factor Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Core Binding Factor Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05881265Phase 2 · recruiting Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02085408Phase 3 · completed Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03735875Phase 1/Phase 2 · terminated Venetoclax and Quizartinib in Treating Patients With FLT3-mutated Recurrent or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06316960Phase 2 · recruiting Safety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Core Binding Factor Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06544109Phase 2/Phase 3 · enrolling by invitation Venetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05832320NA · unknown Optimum Induction Therapy of Low-risk APL · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04793919Phase 2 · recruiting Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01578109Phase 1 · completed Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02192619unknown National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup · condition mapped CURATED_BROADER · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04996030Phase 1 · suspended A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897490recruiting RWE of 1st Line Treatment With ATO/ATRA for Adult APL · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00540995Phase 1/Phase 2 · terminated Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01523223Phase 1 · completed Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03701295Phase 1/Phase 2 · completed Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05504408unknown Observational Study for the Evaluation of Incidence of Systemic Mastocytosis in t(8;21) Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02122081Phase 1 · completed Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003861active not recruiting Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02299518Phase 1 · completed Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05876832Phase 3 · not yet recruiting A Study of XY0206 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory AML With FLT3-ITD-Mutation (ALIVE) · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05821738Phase 2 · unknown Avapritinib in CBF-AML With KIT Mutations · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Core Binding Factor Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01238211Phase 2 · completed Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01028716Phase 2 · terminated Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00119366Phase 2 · terminated Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05596968unknown The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCT · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05596981unknown The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCT · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05497310Phase 1/Phase 2 · unknown Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APL · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00866918Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01472107completed Study on Number and Outcome of Pregnancy in Acute Promielocitic Leukaemia (APL) Patients Treated With Chemotherapy · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03624270Phase 2 · unknown Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04251754unknown The Acute Promyelocytic Leukaemia Asian Consortium (APL-AC) Project · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04689815Phase 2 · unknown Oral Arsenic Trioxide for NPM1-mutated AML · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with NPM1 Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01555268Phase 1 · completed Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01168219Phase 2 · completed Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01253070Phase 2 · completed Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01550185Phase 1 · terminated Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005277completed Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05404516Phase 2 · unknown Combination of Sorafenib With Standard Therapy in Newly Diagnosed Adult CBF AML · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Core Binding Factor Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04788420completed Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD AML · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02200978Phase 4 · completed A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Childhood Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01876953Phase 1/Phase 2 · terminated Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04174612Phase 3 · unknown AML Patients Bearing FLT3 Mutations Based on Peripheral Blast Clearance · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352365Phase 2 · completed Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03751917unknown Long-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01404949Phase 2 · completed Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02899169Phase 3 · unknown Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF) · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02105116NA · terminated AML Therapy With Irradiated Allogeneic Cells · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02144675Phase 2 · completed Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00860574Phase 2 · completed Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00536601NA · completed High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01307579Phase 3 · completed Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096496unknown Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00489203Phase 2 · completed Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445080Phase 1/Phase 2 · completed Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01064570Phase 2 · unknown AIDA 2000 Guidelines · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01246622Phase 1 · completed Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04562818completed Results From a Mexican Acute Promyelocytic Leukemia. · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869777NA · completed Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01235572Phase 2 · completed Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01839240Phase 1 · completed Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02316964Phase 1 · completed Decitabine, Donor Natural Killer Cells, and Aldesleukin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00040846Phase 2 · completed Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045435Phase 2 · completed Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089011Phase 2 · completed Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014235NA · completed Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00078858Phase 1/Phase 2 · completed Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01664897Phase 2 · completed Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04175587Phase 3 · unknown Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APL · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01707004Phase 2 · completed Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00008177Phase 1 · completed Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00856388NA · completed Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00105001Phase 2 · completed Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01529827Phase 2 · completed Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005799NA · completed Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01987297Phase 4 · unknown Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01519596NA · completed Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01839916Phase 2 · completed Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02634827Phase 2 · terminated Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Myeloid Leukemia with FLT3/ITD Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01159067Phase 2 · terminated Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00895934Phase 1/Phase 2 · completed Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00413166Phase 2 · completed All-trans Retinoic Acid, and Arsenic +/- Idarubicin · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02030405Phase 2 · terminated Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01175785Phase 2 · completed Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01031368Phase 1 · completed Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00416598Phase 2 · completed Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01849276Phase 1 · terminated Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02086773Phase 1 · completed Red Cell Transfusion Goals in Patients With Acute Leukemias · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01093586Phase 2 · completed Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02019069Phase 2 · completed CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01904643Phase 1 · terminated Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01273766Phase 2 · completed Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039091Phase 1 · terminated Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01253447Phase 2 · completed AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00795002Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01789255Phase 2 · completed Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01872819NA · completed Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01768897Phase 1 · completed CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01548911Phase 2 · withdrawn Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00666588Phase 2 · completed Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01835288Phase 2 · withdrawn Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02991066unknown Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357032Phase 2 · completed PXD101 in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01801046Phase 1 · terminated Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01798901Phase 1 · completed AR-42 and Decitabine in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00602225Phase 1/Phase 2 · completed Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01842139Phase 1 · completed Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01869803approved for marketing Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00852709Phase 1 · terminated Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01564277Phase 2 · terminated Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01902329Phase 1 · completed A Safety Study of SGN-CD33A in AML Patients · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445744NA · completed Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02049801Phase 1 · terminated MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01831232NA · completed Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01101880Phase 2 · completed Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Advanced Myeloproliferative Neoplasm · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254578Phase 1 · completed Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005940Phase 2 · completed Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01141725Phase 1/Phase 2 · completed Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01349972Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00462605Phase 2 · completed MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00839982Phase 1/Phase 2 · completed Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01342887Phase 1/Phase 2 · terminated Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01076270NA · terminated Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003875Phase 2 · completed Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00673153Phase 2 · terminated Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01083706Phase 2 · completed Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00795769Phase 2 · completed Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049504Phase 2 · completed Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00863434Phase 2 · terminated Clofarabine and Cytarabine in Treating Patients With Acute Myeloid Leukemia With Minimal Residual Disease · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01820624Phase 1 · completed Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01465386Phase 2 · terminated Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01607645Phase 2 · terminated Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052520Phase 1/Phase 2 · completed Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408681NA · completed Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093743Phase 1 · completed Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052598Phase 1/Phase 2 · terminated Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00475150Phase 2 · completed Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00313586Phase 2 · completed Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01226303Phase 3 · unknown Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01870596Phase 2 · completed Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01652014Phase 2 · withdrawn Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01174888Phase 1 · completed Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492401Phase 2 · completed Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00185523terminated Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML) · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02029417Phase 2 · terminated Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01056614Phase 2 · completed Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039117Phase 1 · completed Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00062075Phase 2 · completed Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00459212Phase 1 · completed GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00670150Phase 2 · withdrawn New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01260714Phase 1 · terminated Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01127009Phase 1 · completed Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588809Phase 2 · completed Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00407966Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00634244Phase 2 · completed Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01521936Phase 2 · terminated Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction Chemotherapy · condition mapped ALIAS · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01146223completed Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217646Phase 1 · completed Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ONTOLOGY_EXACT · 264 trials mapped (33 active) | — | — | Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 | 1 | Observed | clinicaltrials | graph → |